In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.24 million shares were traded. ITOS stock price reached its highest trading level at $10.14 during the session, while it also had its lowest trading level at $10.11.
Ratios:
Our goal is to gain a better understanding of ITOS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 28, 2025, Wedbush Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $12.
Leerink Partners Downgraded its Outperform to Market Perform on May 14, 2025, while the target price for the stock was maintained at $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when Detheux Michel sold 43,882 shares for $10.03 per share. The transaction valued at 440,136 led to the insider holds 0 shares of the business.
Detheux Michel sold 43,883 shares of ITOS for $439,708 on Jun 10 ’25. The Chief Executive Officer now owns 0 shares after completing the transaction at $10.02 per share. On Jun 09 ’25, another insider, Detheux Michel, who serves as the Chief Executive Officer of the company, sold 8,400 shares for $10.03 each. As a result, the insider received 84,252 and left with 135,903 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITOS now has a Market Capitalization of 447800704 and an Enterprise Value of -62501320.
Stock Price History:
The Beta on a monthly basis for ITOS is 1.31, which has changed by -0.40932947 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, ITOS has reached a high of $18.01, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 0.01%, while the 200-Day Moving Average is calculated to be 22.38%.
Shares Statistics:
The stock has traded on average 1.40M shares per day over the past 3-months and 1001050 shares per day over the last 10 days, according to various share statistics. A total of 44.17M shares are outstanding, with a floating share count of 42.71M. Insiders hold about 3.37% of the company’s shares, while institutions hold 93.69% stake in the company. Shares short for ITOS as of 1755216000 were 2061672 with a Short Ratio of 2.12, compared to 1752537600 on 3069614. Therefore, it implies a Short% of Shares Outstanding of 2061672 and a Short% of Float of 5.7800002.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of ITeos Therapeutics Inc (ITOS) in the stock market.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.22 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$3.84 and -$3.84 for the fiscal current year, implying an average EPS of -$3.84. EPS for the following year is -$2.68, with 2.0 analysts recommending between -$1.85 and -$3.52.
